100 related articles for article (PubMed ID: 20576386)
1. Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Saida T; Oki A; Yoshikawa H; Minami M
Eur J Radiol; 2011 Nov; 80(2):e91-7. PubMed ID: 20576386
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance evaluation of adnexal masses.
Guerra A; Cunha TM; Félix A
Acta Radiol; 2008 Jul; 49(6):700-9. PubMed ID: 18568564
[TBL] [Abstract][Full Text] [Related]
4. Value of magnetic resonance imaging for the diagnosis of ovarian tumors: a review.
Bazot M; Daraï E; Nassar-Slaba J; Lafont C; Thomassin-Naggara I
J Comput Assist Tomogr; 2008; 32(5):712-23. PubMed ID: 18830100
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.
Yabuuchi H; Fukuya T; Tajima T; Hachitanda Y; Tomita K; Koga M
Radiology; 2003 Feb; 226(2):345-54. PubMed ID: 12563124
[TBL] [Abstract][Full Text] [Related]
6. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
7. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
8. Cartilaginous tumors: fast contrast-enhanced MR imaging.
Geirnaerdt MJ; Hogendoorn PC; Bloem JL; Taminiau AH; van der Woude HJ
Radiology; 2000 Feb; 214(2):539-46. PubMed ID: 10671608
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses.
Takeuchi M; Matsuzaki K; Nishitani H
J Comput Assist Tomogr; 2010; 34(2):173-6. PubMed ID: 20351498
[TBL] [Abstract][Full Text] [Related]
10. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
[TBL] [Abstract][Full Text] [Related]
11. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
12. A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study.
Onishi M; Furukawa A; Takahashi M; Murata K
Eur J Radiol; 2008 Feb; 65(2):286-92. PubMed ID: 17683886
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.
Thomassin-Naggara I; Daraï E; Cuenod CA; Rouzier R; Callard P; Bazot M
J Magn Reson Imaging; 2008 Jul; 28(1):111-20. PubMed ID: 18581400
[TBL] [Abstract][Full Text] [Related]
14. The value of dynamic MRI studies in parotid tumors.
Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
[TBL] [Abstract][Full Text] [Related]
15. Developing an MR imaging strategy for diagnosis of ovarian masses.
Imaoka I; Wada A; Kaji Y; Hayashi T; Hayashi M; Matsuo M; Sugimura K
Radiographics; 2006; 26(5):1431-48. PubMed ID: 16973774
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging.
Chen M; Wang WC; Zhou C; Zhou NN; Cai K; Yang ZH; Zhao WF; Li SY; Li GZ
Chin Med Sci J; 2006 Dec; 21(4):270-5. PubMed ID: 17249204
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of ovarian hemorrhage.
Nishino M; Hayakawa K; Iwasaku K; Togashi K; Ueda H; Sago T; Noguchi M
Eur J Radiol; 2004 Jul; 51(1):34-40. PubMed ID: 15186882
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative differential diagnosis of cystic adnexal tumors: double-contrast MRT].
Reuter M; Steffens JC; Schüppler U; Muhle C; Brinkmann G; Kohl A; Weisner D; Lüttges J; Spielmann RP; Heller M
Rofo; 1996 May; 164(5):394-400. PubMed ID: 8634400
[TBL] [Abstract][Full Text] [Related]
19. Carcinosarcoma of the uterus: MR findings.
Tanaka YO; Tsunoda H; Minami R; Yoshikawa H; Minami M
J Magn Reson Imaging; 2008 Aug; 28(2):434-9. PubMed ID: 18666176
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
